Atlas Trials

Description of Drug Utilization and Assessment of Impact of Saxagliptin on Health Status of Patients With Type 2 Diabetes in France

Clinical trial NCT01552005 · COMPLETED

Trial details

NCT number
NCT01552005
Sponsor
AstraZeneca
Status
COMPLETED
Study type
OBSERVATIONAL
Type 2 Diabetes Mellitus (T2D)
Start date
2012-05-01
Primary completion
2015-06-01
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.